Genetic polymorphism of the hepatic cytochrome P450 2C19 in North Indian subjects

One hundred unrelated healthy North Indian subjects were phenotyped with respect to their ability to metabolize omeprazole to 5‐hydroxyomeprazole. Each volunteer was requested to ingest 20 mg (57.9 μmol) omeprazole. Urine was collected for a period of 8 hours and the amount of 5‐hydroxyomeprazole ex...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical pharmacology and therapeutics 1998-04, Vol.63 (4), p.422-427
Hauptverfasser: Lamba, Jatinder K., Dhiman, Radha K., Kohli, Krishan K.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:One hundred unrelated healthy North Indian subjects were phenotyped with respect to their ability to metabolize omeprazole to 5‐hydroxyomeprazole. Each volunteer was requested to ingest 20 mg (57.9 μmol) omeprazole. Urine was collected for a period of 8 hours and the amount of 5‐hydroxyomeprazole excreted was estimated by HPLC. Histogram, probit, and normal test variable plots showed the antimode value for the log hydroxylation index of omeprazole to be 1.7. Of 100 North Indian subjects, 11 demonstrated log hydroxylation index values more than 1.7. Thus it is inferred that the frequency of occurrence of poor metabolizers of omeprazole in North Indian subjects is 11% (95% confidence interval, 5% to 17%). From the Hardy‐Weinberg Law it was computed that the frequency of occurrence of the mutant allele of hepatic CYP2C19 in the North Indian subjects was 0.33. Clinical Pharmacology & Therapeutics (1998) 63, 422–427; doi:
ISSN:0009-9236
1532-6535
DOI:10.1016/S0009-9236(98)90037-6